Elsevier

Journal of Hepatology

Volume 36, Issue 6, June 2002, Pages 832-850
Journal of Hepatology

Review
Nuclear receptor regulation of hepatic function

https://doi.org/10.1016/S0168-8278(02)00129-0Get rights and content

Introduction

The hepatocyte is responsible for a great portion of the body's metabolic needs including the synthesis and control of pathways involved in cholesterol, fatty acid, carbohydrate, amino acid, serum protein synthesis, bile acids, and the metabolism/detoxification of drugs and xenobiotics. Any attempt to classify these functions into practical groups may miss certain functions, but leads one to appreciate the vast variety of molecules, signals, toxins and functions that all reside simultaneously within each hepatocyte. It is not surprising that the hepatocyte employs multiple layers of regulation in order to perform its functions, and possesses self-protective processes in order to not to destroy itself in the process of handling a large variety of potentially toxic products at relatively high concentrations. One of the more intriguing, and increasingly appreciated, means of hepatic self-regulation is provided by members of the nuclear receptor (NR) superfamily. The activity of these multipartite transcriptional regulators are themselves controlled by the intracellular concentration of specific ligands, many of which are products shuttled about hepatocytes in the course of performing integrated metabolic functions. Thus, nuclear receptors are the ideal candidates to respond to the complex and ever-changing intracellular environment of the hepatocyte, where they can alter the expression of target genes in order to provide the appropriate physiological response in a timely fashion. It is the purpose of this review to attempt to provide an overview of how select members of the NR superfamily act as sensors and regulators in the expression of a wide variety of metabolically-important target hepatic genes, and why these pathways are relevant for the practicing hepatologist and their patients with liver disease.

Nuclear receptors are being increasingly appreciated by hepatic researchers in virtually all disciplines that affect hepatocyte function – including transport, toxicology, pharmacology, metabolism, nutrition, and physiology. Given the breadth of gene regulation by NRs, it is not possible to cover all aspects in this review (see recent review series in the Journal of Biological Chemistry [1]). Rather, I will focus upon recent studies on how specific ligands and NR family members affect basic hepatic functioning, thereby emphasizing the role of eight of the 48 human NR family members (see Fig. 1 and Table 1) [2]. This should not be interpreted that Type I or homodimer-forming, receptors (glucocorticoid, estrogen, androgen, mineralocorticoid, progesterone), nor other Type II, RXR-heterodimer dependent receptors (e.g. vitamin D, thyroid, PPARγ), nor the monomeric receptors (HNF4, COUP-TF), have insignificant roles in hepatic gene regulation; rather that a detailed discussion is beyond the scope of this review [3], [4]. Also excluded from this review will be a discussion of the important roles of NRs on non-parenchymal liver cell function, even though it is clear that resident hepatic macrophages, and stellate cells are themselves regulated by nuclear receptors and ligands [5], [6], [7], [8]. Finally, the reader is referred to several excellent recent reviews in order to gain a deeper understanding the critical role of co-activators and co-repressors in mediating NR function [9], [10], [11], [12], [13].

Section snippets

Nuclear receptors: general overview and basic concepts

In order to better understand the roles and functions of NRs, a few definitions and clarifications may be helpful. There are over 150 known members of the NR superfamily, the general organization has been evolutionarily conserved for millions of years, and NRs are present in all eukaryotic cells. In humans, 48 members of the NR family have been definitively cloned and identified, while detailed analyses of the available sequences from the Human Genome Project may have uncovered a 49th plus

RXRα

The nuclear receptor RXR (retinoid X receptor) was identified in 1990 by Mangelsdorf et al. in a search for additional retinoid receptors by employing low-stringency screening of human liver cDNA libraries with a human retinoic acid receptor α (RARα) DNA-binding domain cDNA probe [28]. There are three family members (RXRα, RXRβ, RXRγ), each of which utilizes 9-cis retinoic acid (9cRA) as a high affinity ligand [29], [30]. RXRα (NR1B1) is most highly expressed in liver, with lesser but

CAR

The nuclear receptor CAR (constitutive androstane receptor, NR1I3) was identified in, 1994 in a screen for nuclear receptor family members [59]. An obligate RXR partner, CAR is emerging as an important regulator of drug, xenobiotic and bilirubin metabolism, and therefore has a central position in hepatocyte functioning. Its developmental expression pattern is unknown, but it is highly expressed in liver in at least two isoforms [60]. There are several RXR:CAR DNA response elements – DR3, DR4,

FXR

Considerable interest and enthusiasm for incorporating the farnesol X receptor (FXR; NR1H4) into the corps of key hepatic gene regulators came in 1999 when three groups reported that bile acids were high affinity ligands for FXR [85], [86], [87]. Although initially named for its low level response to farnesol, it was clear that the true ligand remained to be determined [88]. The prototypical RXR:FXR response element is an IR1, although some authors recently report IR0 and ER8 RXR:FXR binding

LXR

The liver X receptor (LXR) was discovered in 1995 as part of a screen for liver-enriched NR family members, and has become recently recognized as an important regulator of whole-body cholesterol metabolism [121]. There are two distinct gene products, LXRα (NR1H3) and LXRβ (NR1H2), with diverse patterns of expression, but similar target DNA-binding elements and ligands. LXRα is expressed predominantly in liver, kidney, intestine, fat, adrenal, spleen and in macrophages, while LXRβ is relatively

PPARα

It has been known for over 30 years that select substances can lead to massive proliferation of peroxisomes, including the hypolipidemic fibrates (e.g. clofibrate, ciprofibrate, fenofibrate) [148]. Several substances lead to peroxisomal proliferation including very long chain fatty acids, phthalates, suggesting a common controlling metabolic mechanism. The first peroxisomal proliferator activator receptor (PPAR) was identified in, 1990, and soon thereafter other family members, PPAR(β)δ and

PXR/SXR

The pregnane X receptor (PXR) and steroid and xenobiotic receptor (SXR) were discovered by several groups in, 1998 and soon determined to be rodent (PXR) and human (SXR) versions of the same gene (NR1I2) with significantly distinct ligand affinities [182], [183], [184]. The term PXR/SXR will connote common features of both gene products, while attributes of the human and non-human forms will be discussed individually. PXR/SXR is expressed at high levels in liver and intestine and is a master

RAR

The first retinoic acid receptor, RARα, was identified in 1987 by two groups [210], [211]. Two other receptors, RARβ and RARγ were soon discovered, and each of these have complex tissue and developmental expression patterns [212], [213], [214]. RARα (NR1B1) is the most prevalent isoform in liver and hepatocytes. The endogenous high affinity ligand ATRA, which endogenously is also a source for 9cRA, thereby complicating the interpretation of using ATRA in early experimental studies. A synthetic

SHP

Over the past 2 years, an orphan NR with substantial transcriptional regulatory properties, yet without a DNA-binding domain, has emerged as a central responder to counteract to elevated intracellular bile acid levels. The orphan NR small heterodimer partner (SHP, NR0B2) was identified in 1996 during a screen for NR family members [235]. Its structure revealed a dimerization domain and LBD, but no DBD. SHP appears to repress the function of other NRs by several mechanisms, including

Integration of NR regulation of physiological processes within the liver

The expansive array of ligands, target genes, and metabolic processes regulated by NRs within hepatocytes, and the ever-changing internal milieu, makes a completely comprehensive regulatory scheme virtually impossible to depict graphically. What is apparent is that many of the regulatory ligands are themselves substrates for the target enzymes they induce, and that there is considerable crosstalk among ligands and pathways. Two examples which highlight how multiple NRs coordinate hepatic

Relevance of nuclear receptors for the practicing hepatologist

Given the broad range of processes within the liver under NR control, and their responses to a variety of drugs/toxins and disease states, it should be apparent that a working knowledge of these pathways has relevance to practitioners caring for patients with liver disease (Table 3). In our daily practice, we prescribe drugs that are known or potential NR ligands (e.g. steroids, rifampin, UDCA), deal with the consequences of cholestasis, yet are virtually unable to medically halt the

Acknowledgments

A review of this nature cannot include all references and I apologize for the many important references that have been excluded. David D. Moore's sharing of unpublished information is gratefully acknowledged as well as the continued interest, enthusiasm, and comments of the Karpen laboratory.

First page preview

First page preview
Click to open first page preview

References (243)

  • H.E. Xu et al.

    Molecular recognition of fatty acids by peroxisome proliferator- activated receptors

    Mol Cell

    (1999)
  • W. Bourguet et al.

    Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis

    Protein Expr Purif

    (2000)
  • Q. Zhao et al.

    Structural basis of RXR–DNA interactions

    J Mol Biol

    (2000)
  • D.J. Mangelsdorf et al.

    The RXR heterodimers and orphan receptors

    Cell

    (1995)
  • R.A. Heyman et al.

    9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

    Cell

    (1992)
  • M. Leid et al.

    Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently

    Cell

    (1992)
  • K. Umesono et al.

    Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors

    Cell

    (1991)
  • D.J. Mangelsdorf et al.

    A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR

    Cell

    (1991)
  • A. Rowe

    Retinoid X receptors

    Int J Biochem Cell Biol

    (1997)
  • D.J. Mangelsdorf et al.

    The nuclear receptor superfamily: the second decade

    Cell

    (1995)
  • H. Mano et al.

    Positive and negative regulation of retinoid X receptor gene expression by thyroid hormone in the rat. Transcriptional and post-transcriptional controls by thyroid hormone

    J Biol Chem

    (1994)
  • H.H. Steineger et al.

    Gene transcription of the retinoid X receptor alpha (RXRalpha) is regulated by fatty acids and hormones in rat hepatic cells

    J Lipid Res

    (1998)
  • A.P. Beigneux et al.

    The acute phase response is associated with retinoid X receptor repression in rodent liver

    J Biol Chem

    (2000)
  • S. Adam-Stitah et al.

    Hyperphosphorylation of the retinoid X receptor alpha by activated c- Jun NH2-terminal kinases

    J Biol Chem

    (1999)
  • H.Y. Lee et al.

    Stress pathway activation induces phosphorylation of retinoid X receptor

    J Biol Chem

    (2000)
  • S. Adachi et al.

    Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma

    Hepatology

    (2002)
  • H.S. Choi et al.

    Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR

    J Biol Chem

    (1997)
  • J. Sugatani et al.

    The phenobarbital response enhancer module in the human bilirubin UDP- glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR

    Hepatology

    (2001)
  • H.R. Kast et al.

    Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

    J Biol Chem

    (2002)
  • I. Tzameli et al.

    Role reversal: new insights from new ligands for the xenobiotic receptor CAR

    Trends Endocrinol Metab

    (2001)
  • L.B. Moore et al.

    Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands

    J Biol Chem

    (2000)
  • D.J. Waxman

    P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR

    Arch Biochem Biophys

    (1999)
  • T. Sueyoshi et al.

    The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene

    J Biol Chem

    (1999)
  • I. Zelko et al.

    Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes

    Biochem Biophys Res Commun

    (2000)
  • W. Xie et al.

    Orphan nuclear receptors: the exotics of xenobiotics

    J Biol Chem

    (2001)
  • S. Gerbal-Chaloin et al.

    Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor

    J Biol Chem

    (2002)
  • N. Hagenbuch et al.

    Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver

    J Hepatol

    (2001)
  • Y. Cui et al.

    Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6

    J Biol Chem

    (2001)
  • H. Wang et al.

    Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

    Mol Cell

    (1999)
  • B.M. Forman et al.

    Identification of a nuclear receptor that is activated by farnesol metabolites

    Cell

    (1995)
  • B.A. Laffitte et al.

    Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor

    J Biol Chem

    (2000)
  • N.L. Urizar et al.

    The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression

    J Biol Chem

    (2000)
  • T.T. Lu et al.

    Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism

    J Biol Chem

    (2001)
  • B. Goodwin et al.

    A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

    Mol Cell

    (2000)
  • A. Chawla et al.

    ‘Don't know much bile-ology’

    Cell

    (2000)
  • D.W. Russell

    Nuclear orphan receptors control cholesterol catabolism

    Cell

    (1999)
  • P.A. Edwards et al.

    BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis

    J Lipid Res

    (2002)
  • C.J. Sinal et al.

    Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis

    Cell

    (2000)
  • S. Gupta et al.

    Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway

    J Biol Chem

    (2001)
  • J.H. Miyake et al.

    Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase

    J Biol Chem

    (2000)
  • Cited by (148)

    • Mechanisms of Hepatocyte Organic Anion Transport

      2018, Physiology of the Gastrointestinal Tract, Sixth Edition
    View all citing articles on Scopus
    View full text